Iman Osman - Concepedia

Author

Iman Osman

Also Known As

Eva Hernando, Eva Hernando-Monge, Gerstenblith, M., H Elshafie, I Osman, I. Osman, IMAN OSMAN, Igbal E. Osman, Imam Irshad Osman, Iman Osman

715

Publications

19K

Citations

H-Index

151

Concepts

All Affiliations

New York University Eastern Cooperative Oncology Group NYU Langone Health Memorial Sloan Kettering Cancer Center Cornell University

About

Iman Osman is an author at New York University specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	43	81	8.9K
2	Health Sciences	8	8	876
3	Engineering	7	7	730
4	Natural Sciences	2	2	97
5	Education	1	1	47

Iman Osman

188

Publications

17.1K

Citations

H-Index

Page 1

	Year	Citations
BRAF mutation predicts sensitivity to MEK inhibition David B. Solit, Levi A. Garraway, Christine A. Pratilas, Nature Signal TransductionBraf MutationGenetic DisorderMedicineGenetics	2005	1.3K
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies Luping Lin, Amit J. Sabnis, Elton Chan, Nature Genetics MedicineMek-targeted Cancer TherapiesHippo Effector YapCancer BiologyCell Biology	2015	548
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor Miguel F. Segura, Douglas Hanniford, Sílvia Menéndez, Proceedings of the National Academy of Sciences Melanoma Cell LinesTumor BiologySystems BiologyMirna ClusterMedicine	2009	541
Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment Dalia Barkley, Reuben Moncada, Maayan Pour, Nature Genetics Tumor HeterogeneityMedicineBiological MicroenvironmentsTumor TypesCancer Biology	2022	492
Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis Douglas Hanniford, Alejandro Ulloa‐Morales, Alcida Karz, Cancer Cell Epigenetic SilencingMedicineMelanomaCell BiologyCancer Biology	2020	411
Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade Inês Pires da Silva, Anne Gallois, Sonia Jiménez-Baranda, Cancer Immunology Research ImmunologyNk CellsImmunoeditingImmunologic MechanismCd4 T Cell Responses	2014	399
The histone variant macroH2A suppresses melanoma progression through regulation of CDK8 Avnish Kapoor, Matthew S. Goldberg, Lara Cumberland, Nature Tumor BiologyChromatinChromatin StructureCell RegulationMedicine	2010	395
Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival Dusan Bogunovic, David O’Neill, Ilana Belitskaya‐Lévy, Proceedings of the National Academy of Sciences	2009	375
Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations Curtis H. Kugel, Stephen M. Douglass, Marie R. Webster, Clinical Cancer Research	2018	347
miR-30b/30d Regulation of GalNAc Transferases Enhances Invasion and Immunosuppression during Metastasis Avital Gaziel‐Sovran, Miguel F. Segura, Raffaella Di Micco, Cancer Cell Tumor BiologyMedicineImmunologyMir-30b/30d RegulationSmall Rna	2011	339

Page 1